A Multicentre, Phase 3, Clinical Study to Compare the Striatal Uptake of a Dopamine Transporter Radioligand, DaTSCAN™ Ioflupane (123I) Injection, After Intravenous Administration to Chinese Patients With a Diagnosis of Parkinson's Disease, Multiple System Atrophy, Progressive Supranuclear Palsy, or Essential Tremor and to Healthy Controls

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04193527

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:39:31.454785+00:00

Published At

2023-10-16T00:00:00+00:00

Record Updated At

2023-10-16

Results Posted At

2023-10-16

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Parkinsonian Syndrome", "Parkinson Disease(PD)", "Multiple System Atrophy (MSA)", "Progressive Supranuclear Palsy (PSP)", "Essential Tremor"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2023-10-16"

protocolSection.identificationModule.nctId

"NCT04193527"

protocolSection.identificationModule.officialTitle

"A Multicentre, Phase 3, Clinical Study to Compare the Striatal Uptake of a Dopamine Transporter Radioligand, DaTSCAN\u2122 Ioflupane (123I) Injection, After Intravenous Administration to Chinese Patients With a Diagnosis of Parkinson\u0027s Disease, Multiple System Atrophy, Progressive Supranuclear Palsy, or Essential Tremor and to Healthy Controls"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2023-10-16"

Study condition terms

• Parkinsonian Syndrome (protocolSection.conditionsModule.conditions)
• Parkinson Disease(PD) (protocolSection.conditionsModule.conditions)
• Multiple System Atrophy (MSA) (protocolSection.conditionsModule.conditions)
• Progressive Supranuclear Palsy (PSP) (protocolSection.conditionsModule.conditions)
• Essential Tremor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.